Rifampicin‐induced acute tubulointerstitial nephritis during pulmonary tuberculosis treatment: A case report
Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubuloin...
Saved in:
Published in | Respirology case reports Vol. 11; no. 8; pp. e01190 - n/a |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.08.2023
John Wiley & Sons, Inc Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Drug‐induced tubulointerstitial nephritis is an uncommon complication in patients on anti‐tuberculosis therapy that can lead to permanent kidney damage. Rifampicin is the most offending drug. We report a case of a 41‐years old man being treated for pulmonary tuberculosis and presenting with tubulointerstitial nephritis associated with rifampicin. We focus on diagnosis features and therapeutic challenges.
We present a case of rifampicin‐induced acute renal failure due to acute tubulointerstitial nephritis (ATIN), successfully managed with second‐line anti‐TB treatment. |
---|---|
Bibliography: | ObjectType-Case Study-2 SourceType-Scholarly Journals-1 content type line 23 ObjectType-Report-1 Associate Editor: Andrea Ban Yu‐Lin |
ISSN: | 2051-3380 2051-3380 |
DOI: | 10.1002/rcr2.1190 |